How many drugs treat Carnitine deficiency?

Drug Landscape tracks 1 marketed treatments for Carnitine deficiency (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/carnitine-deficiency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Carnitine deficiency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Carnitine deficiency (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Carnitine deficiency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Carnitor	LEVOCARNITINE	Leadiant Biosci Inc	Carnitine Analog [EPC]	Carnitine O-palmitoyltransferase 1, liver isoform		1985-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Leadiant Biosci Inc · 1 drug in Carnitine deficiency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Carnitine deficiency:

Cite this brief

Drug Landscape (2026). Carnitine deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/carnitine-deficiency. Accessed 2026-06-10.

Carnitine deficiency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing